Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia

Autor: Jean-Hugues Guervilly, Filippo Rosselli, Gaëtane Mace-Aime
Přispěvatelé: Génomes et cancer (GC (FRE2939)), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Centre National de la Recherche Scientifique (CNRS)
Rok vydání: 2007
Předmět:
environment and public health
chemistry.chemical_compound
0302 clinical medicine
Fanconi anemia
hemic and lymphatic diseases
MESH: RNA
Small Interfering

Monoubiquitination
RNA
Small Interfering

Luciferases
Genetics (clinical)
0303 health sciences
Lymphoblast
Fanconi Anemia Complementation Group D2 Protein
General Medicine
Cell biology
Crosstalk (biology)
030220 oncology & carcinogenesis
Phosphorylation
biological phenomena
cell phenomena
and immunity

G2 Phase
MESH: Enzyme Activation
[SDV.OT]Life Sciences [q-bio]/Other [q-bio.OT]
animal structures
DNA damage
Biology
MESH: Fanconi Anemia Complementation Group D2 Protein
Transfection
Models
Biological

03 medical and health sciences
FANCD2
Genetics
medicine
Humans
Molecular Biology
MESH: Protein Kinases
030304 developmental biology
MESH: DNA Damage
MESH: Humans
MESH: Transfection
MESH: Models
Biological

Ubiquitination
medicine.disease
Molecular biology
MESH: Hela Cells
Enzyme Activation
enzymes and coenzymes (carbohydrates)
MESH: Fanconi Anemia
MESH: G2 Phase
Fanconi Anemia
chemistry
Checkpoint Kinase 1
MESH: Ubiquitination
MESH: Luciferases
Protein Kinases
DNA
DNA Damage
HeLa Cells
Zdroj: Human Molecular Genetics
Human Molecular Genetics, Oxford University Press (OUP), 2008, 17 (5), pp.679-89. ⟨10.1093/hmg/ddm340⟩
ISSN: 1460-2083
0964-6906
Popis: Fanconi anemia (FA) is a cancer-prone hereditary disease resulting from mutations in one of the 13 genes defining the FANC/BRCA pathway. This pathway is involved in the cellular resistance to DNA-cross-linking agents. How the FANC/BRCA pathway is activated and why its deficiency leads to the accumulation of FA cells with a 4N DNA content are still poorly answered questions. We investigated the involvement of ATR pathway members in these processes. We show here that RAD9 and RAD17 are required for DNA interstrand cross-link (ICL) resistance and for the optimal activation of FANCD2. Moreover, we demonstrate that CHK1 and its interacting partner CLASPIN that act downstream in the ATR pathway are required for both FANCD2 monoubiquitination and assembling in subnuclear foci in response to DNA damage. Paradoxically, in the absence of any genotoxic stress, CHK1 or CLASPIN depletion results in an increased basal level of FANCD2 monoubiquitination and focalization. We also demonstrate that the ICL-induced accumulation of FA cells in late S/G2 phase is dependent on ATR and CHK1. In agreement with this, CHK1 phosphorylation is enhanced in FA cells, and chemical inhibition of the ATR/CHK1 axis in FA lymphoblasts decreases their sensitivity to mitomycin C. In conclusion, this work describes a complex crosstalk between CHK1 and the FANC/BRCA pathway: CHK1 activates this pathway through FANCD2 monoubiquitination, whereas FA deficiency leads to a CHK1-dependent G2 accumulation, raising the possibility that the FANC/BRCA pathway downregulates CHK1 activation.
Databáze: OpenAIRE